TARA
Protara Therapeutics Inc
3.70$
+4.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +115.8% | +20.3% | -22.3% | -86.1% | +1,125.0% | +495.4% | -78.8% | +38.1% | -2.6% | +9.0% | |
| – | -101.9% | – | – | – | – | – | – | – | – | – | – | |
| – | +92.5% | +52.4% | +14.9% | -28.5% | -58.5% | +84.6% | +77.5% | -20.3% | +47.5% | +27.9% | +34.5% | |
| – | +107.3% | +15.9% | -98.9% | +9,876.5% | -16.6% | +154.8% | +17.5% | -21.5% | -10.2% | -6.3% | +25.6% | |
| – | +97.7% | +37.3% | +5.7% | -13.7% | -41.5% | +124.5% | +38.7% | +41.2% | -35.5% | +13.6% | +30.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -83.2% | +34.0% | +34.2% | -100.0% | – | – | +5,008.8% | -34.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -107.1% | – | +76.6% | +714.5% | -104.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.